Michael Jerman

Michael Jerman

Director/Miembro de la Junta en HEDGEPATH PHARMACEUTICALS INC .

Fortuna: 51 274 $ al 31/05/2026

42 años
Health Technology
Consumer Services
Commercial Services

Perfil

Mr. Michael A. Jerman is an Independent Director at Alaunos Therapeutics, Inc., an Independent Director at Inhibitor Therapeutics, Inc. and a Managing Partner at Hollywell Partners LLC.
He is on the Board of Directors at Alaunos Therapeutics, Inc. and Inhibitor Therapeutics, Inc. Mr. Jerman was previously employed as an Independent Director by MIRA Pharmaceuticals, Inc. and an Independent Director by Telomir Pharmaceuticals, Inc. He also served on the board at PricewaterhouseCoopers LLP.
He received his undergraduate degree from the University of South Florida, a graduate degree from The University of Tampa, Inc. and an MBA from the University of Oxford.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
29/04/2026 15.621 ( 0,64 % ) 44 520 $ 31/05/2026
01/04/2025 80.411 ( 0,05 % ) 6 755 $ 31/05/2026

Cargos activos de Michael Jerman

EmpresasCargoInicio
HEDGEPATH PHARMACEUTICALS INC Director/Miembro de la Junta 24/05/2023
ALAUNOS THERAPEUTICS, INC. Director/Miembro de la Junta 15/07/2025
Corporate Officer/Principal 01/05/2019

Antiguos cargos conocidos de Michael Jerman.

EmpresasCargoFin
TELOMIR PHARMACEUTICALS, INC. Director/Miembro de la Junta 18/11/2024
MIRA PHARMACEUTICALS, INC. Director/Miembro de la Junta 18/11/2024
Director/Miembro de la Junta 01/08/2019
Ver el detalle de la experiencia de Michael Jerman.

Formación de Michael Jerman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

97

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN